NCT03478657 An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma Status COMPLETED Phase PHASE4
NCT03478644 Oral and Dermal Tolerability Clinical Study of an Experimental Denture Wipe Status COMPLETED Phase NA
NCT03474081 A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE4
NCT03467425 INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design Status COMPLETED Phase PHASE4
NCT03465332 Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment Decisions Status COMPLETED Phase N/A
NCT03463577 The Safety of Boostrix Following Routine Immunization of Pregnant Women Status COMPLETED Phase N/A
NCT03457727 GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects Status COMPLETED Phase PHASE1
NCT03457701 Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) Status COMPLETED Phase PHASE2
NCT03447314 Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03446612 Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF) Status TERMINATED Phase PHASE2
NCT03446573 Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO) Status COMPLETED Phase PHASE3
NCT03443427 A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine Status COMPLETED Phase PHASE2
NCT03441984 To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03441113 Extended Access of Momelotinib in Adults With Myelofibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03439657 Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older Status COMPLETED Phase PHASE3
NCT03438006 A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects Status COMPLETED Phase N/A
NCT03436511 Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT03433482 A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age Status COMPLETED Phase PHASE2
NCT03426995 First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699 Status TERMINATED Phase PHASE1
NCT03425201 Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA) Status COMPLETED Phase PHASE1/PHASE2